Recent Research | Page 17 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort descending Journal Bone Marrow Disease
Prognostication in Myelodysplastic Syndromes: Beyond the International Prognostic Scoring System (IPSS) Apr 2013 Am J Med myelodysplastic syndromes (MDS)
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems. Apr 2013 Leuk Lymphoma myelodysplastic syndromes (MDS)
Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes. Apr 2013 Leuk Lymphoma myelodysplastic syndromes (MDS)
Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia. Apr 2013 Pediatr Transplant aplastic anemia
How we treat lower risk myelodysplastic syndromes. Apr 2013 Blood myelodysplastic syndromes (MDS)
A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. Apr 2013 Haematologica myelodysplastic syndromes (MDS)
Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia. Apr 2013 Pediatr Transplant aplastic anemia
Validation of the revised international prognostic scoring system in treated patients with myelodysplastic syndromes. Apr 2013 Am J Hematol myelodysplastic syndromes (MDS)
Thrombosis in paroxysmal nocturnal hemoglobinuria. Apr 2013 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations. Apr 2013 Br J Haematol myelodysplastic syndromes (MDS)